AMERICAS GOLD AND SILVER CORPORATION (USAS): what the price requires
At today's price, AMERICAS GOLD AND SILVER CORPORATION (USAS) is priced for today's economics sustained for ~28.5 years. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.
Generated: 2026-07-19 · Exported: 2026-07-20 · Source: https://boothcheck.com/report/USAS
Headline
| Field | Value |
|---|---|
| Ticker | USAS |
| Company | AMERICAS GOLD AND SILVER CORPORATION |
| Sector / Industry | Basic Materials |
| Current price | $3.79/sh |
What The Price Requires (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | revenue-multiple |
| EV / sales paid | 14.5x |
| Steady-state operating margin assumed | 11.2% |
| Must persist for | 28.5y |
Solve inputs: computed at a 13.2% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~3.6 years.
Reconcile: at the x-ray's 9.3% required return this reads ~16.9 years; the models below use their own rates.
How unusual the bet is: elevated (limited comparison data)
| Reference | Value |
|---|---|
| sustained it ~10 years at this level | 15% |
| implied end-window share | 0% |
Valuation X-Ray
Every valuation family lands below the price. The price therefore requires assumptions beyond what those standard frames encode.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 4.81x | 2 | expensive |
| Earnings | — | 0 | — |
| Relative | 5.47x | 2 | expensive |
| Growth | — | 0 | — |
Families that call it expensive: Asset, Relative
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.8%); the inversion above states its own rate.
Per-Model Detail (n=4)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $0.00 | — | no | Negative/zero FCF — equity value floored at $0 |
| DCF Exit Multiple | Growth | $0.00 | — | no | Negative/zero FCF or EBITDA — equity value floored at $0 |
| Relative Valuation | Relative | $0.66 | 5.74x | yes | P/S fallback (negative EPS): Sector P/S 1.5x × TTM revenue — excluded from consensus |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $0.83 | 4.57x | yes | Reference only (book value floor): BV/sh $0.83, ROE negative |
| Two-Stage Excess Return | Asset | $0.75 | 5.05x | yes | Reference only (book value with convergence): BV/sh $0.83, ROE converges to ke |
| Discounted Future Market Cap | Growth | $3.68 | 1.03x | no | Rev $0.1B, growth 28% (input: historical growth; tapered), Terminal P/S: 4.5x / 6.0x / 7.2x (bear / base = today's held flat / bull, cap 6x) |
| Peter Lynch Fair Value | Relative | $0.00 | — | no | Negative/zero EPS — earnings-based value floored at $0 |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | — | — | no | — |
| Residual Income | Asset | — | — | no | — |
| Graham Number | Asset | — | — | no | — |
| EV/EBITDA Relative | Relative | $0.73 | 5.19x | yes | EBITDA $0.02B × sector EV/EBITDA 8.0x |
| FCF Yield | Earnings | — | — | no | — |
| SBC-Adj FCF Yield | Earnings | — | — | no | — |
| Ben Graham Formula | Earnings | — | — | no | — |
| ROIC-Justified P/B | Asset | — | — | no | — |
| P/Sales Sector | Relative | $0.66 | 5.74x | no | Revenue $0.12B × sector P/S 1.5x |
| PEG Fair Value | Relative | — | — | no | — |
| Earnings Yield | Earnings | — | — | no | — |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net cash | $129.8m |
| Interest coverage | -14.6x |
| Share count CAGR (dilution) | 11.9% |
| Burning cash | yes |
Operating profit is negative or near zero and the company has no demonstrated through-cycle (mid-cycle) operating margin to normalize against, so years-to-repay cannot be computed honestly.
Bullet Takeaways
- The balance sheet is the story's foundation: about $130 million of net cash and no debt, which funds the Galena ramp without forcing a sale of the mine or the company.
- The risk is equally plain, because the business still loses money at the operating line and trades well above every standard valuation estimate, so the price is paying for a turnaround that has not yet reached profit.
- Watch production and cost, where 2026 guidance calls for 3.2 to 3.6 million ounces of silver at an all-in cost of $30 to $35 an ounce against capital spending of $90 to $120 million that could outrun the cash on hand.
Bull Case
Start with the one number that most changes the odds here: the balance sheet. At $3.79 a share (July 19, 2026), Americas Gold and Silver carries about $130 million in net cash and no debt at all. For a roughly billion-dollar miner in the middle of rebuilding a century-old silver district, that is the difference between funding the work from strength and funding it at the market's mercy. A debt-free balance sheet means no lender can force a restructuring when a quarter comes in soft, and it buys the time a mine ramp always needs.
That cash is buying a genuine inflection in the mines. In the first quarter of 2026 the company produced a record 787,000 ounces of silver, up 76% from a year earlier, as the Galena Complex in Idaho lifted output 35% and the Cosalá operation in Mexico brought its EC120 zone into commercial production. Consolidated revenue rose 187% to $67.8 million in that quarter alone. Full-year guidance targets 3.2 to 3.6 million ounces, roughly a third more than the prior year. The plan is no longer a promise on a slide; the ounces are showing up.
And the ounces are arriving into the strongest silver market in a generation. Silver set an all-time high above $95 an ounce in January 2026, and forecasters at J.P. Morgan see it averaging near $81 for the year, roughly double the prior year. A producer still climbing its cost curve gets the most leverage from a rising metal price, because every dollar the silver price runs above all-in costs of $30 to $35 an ounce falls toward the bottom line. If the ramp holds and silver stays bid, the same operating leverage that makes the trailing numbers look ugly works just as hard in reverse.
Bear Case
The distance between what this company does and what its shares cost is the entire bear case. Americas Gold and Silver does not yet earn an operating profit; over the trailing year it lost money running the mines. Yet at $3.79 a share the market still values the whole company at roughly a billion dollars. Set that price against the business as it actually is and every standard lens strains: the price sits about 4.8 times the value the asset-based methods assign, and higher still against what peer multiples support. A silver miner repriced this hard into a roaring silver tape is not being valued on its output. It is being valued on a story about output several years from now.
Put the requirement in plain terms. Because there is no profit to value, the price leans on sales, and at about 14.5 times revenue it implies the business eventually earns something like an 11.2% operating margin and grows at the fastest pace it can self-fund for about 30 years. That is a long time to hold one assumption in a cyclical business. Of the fast-growing companies that have reached for that kind of run, only about one in seven sustained it even a decade. This is a low-confidence read by construction, because a company without steady profits gives the methods little to grip, but the direction is unambiguous: today's price already discounts a decade or more of near-flawless execution.
How the company got its clean balance sheet is itself the risk. The cash came from selling shares, repeatedly. The share count has grown about 12% a year over the last four years, and in the last year alone dilution ran near 36% as the company raised $132 million in a December bought deal, handed shares to a streaming partner, and paid for the Crescent Mine acquisition in stock. Existing holders funded the ramp by owning less of it each round. The pressure does not stop, since 2026 capital spending is guided at $90 to $120 million against about $130 million of cash, so unless the mines throw off cash quickly, another raise and more dilution is the likely bridge. Concentrate that on two assets whose economics still depend on a high silver price and a clean Galena rebuild, and the downside is not academic.
Valuation
At $3.79 a share, this is a company the standard methods cannot value cleanly, and the honest version of the analysis says so out loud. There is no operating profit to capitalize, so the earnings-power and growth lenses simply do not apply. What remains are the asset-based and peer comparison methods, and both land far below the price: the price sits about 4.8 times the asset-based estimate and higher still against the peer comparison. Every family of method lands beneath today's quote. The price, in other words, requires something none of these frames contains.
With no profit to anchor on, the price is set against sales, and there it runs to about 14.5 times revenue. Invert that and the market is paying today for the business to grow at the fastest pace it can fund itself, hold that pace for about 30 years, and settle at roughly an 11.2% operating margin. Keep those figures approximate, because they come from a single solve on a business that does not yet generate the steady cash such a model assumes. The takeaway is not the decimal places. It is that today's price already embeds a decade or more of uninterrupted growth in a metal business that has rarely been uninterrupted.
The balance sheet is the one place the picture is unambiguous. The company holds about $130 million of net cash and carries no debt, which is why it can keep spending through the ramp. But cash is not the same as cash flow, and the operating line is still negative, while the capital budget for the year sits at $90 to $120 million, within reach of exhausting the cash before the mines cover it. The valuation question here is really a timing question. The methods value what the business earns, and it does not yet earn. The price values what it might earn once Galena and Cosalá run at full stride and silver stays high. Those are two different companies, and the gap between them is the whole investment.
Catalysts
The story turned on the first quarter of 2026, reported in May. Americas Gold and Silver posted record consolidated silver production of 787,000 ounces, up 76% year over year, with sales of 830,000 ounces; the Galena Complex contributed 425,000 ounces and Cosalá 362,000 as its EC120 zone reached commercial production on January 1, 2026. Consolidated revenue climbed 187% to $67.8 million, and all-in sustaining cost came in at $34.12 an ounce, inside the full-year range.
For the full year the company guides 3.2 to 3.6 million ounces of silver at an all-in cost of $30 to $35, with capital spending of $90 to $120 million and exploration of $15 to $20 million as it upgrades the No. 3 Shaft and shifts Galena from conventional to mechanized mining. The macro backdrop is doing its part, with silver reaching a record above $95 an ounce in January 2026 and J.P. Morgan projecting an average near $81 for the year.
The next read is second-quarter 2026 results, due in August, and the questions are concrete: did the production ramp hold or accelerate, did all-in costs stay inside guidance as mechanization scales, and how fast is the cash balance drawing down against the capital plan. A single soft quarter would not threaten a debt-free company, but it would sharpen the financing question the share count has already been answering.
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.
Sources
Americas Gold and Silver 2026 guidance · Americas Gold and Silver Q1 2026 results · J.P. Morgan Global Research and market data, January 2026 · company financing disclosures, 2025 · company disclosures, 2026